CIK 0000882291
- Non-accelerated filer
- Smaller reporting company
AETHLON MEDICAL INC
Sign in to watch- Ticker
- AEMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 133632859
- Phone
- +1 619-941-0360
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121
- Former names
- BISHOP EQUITIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-03-19 | BARRY FRANKLYN S JR Director | Sale | −7,400 | $0.39 | $3K | 221,193 |
| 2010-03-18 | BROENNIMAN EDWARD G Director | Sale | −7,200 | $0.38 | $3K | 454,174 |
| 2010-03-18 | BARRY FRANKLYN S JR Director | Sale | −7,200 | $0.38 | $3K | 228,593 |
| 2010-03-17 | BROENNIMAN EDWARD G Director | Sale | −7,100 | $0.41 | $3K | 461,374 |
| 2010-03-17 | BARRY FRANKLYN S JR Director | Sale | −7,100 | $0.40 | $3K | 235,793 |
| 2010-03-16 | BROENNIMAN EDWARD G Director | Sale | −7,000 | $0.39 | $3K | 468,474 |
| 2010-03-16 | BARRY FRANKLYN S JR Director | Sale | −7,000 | $0.40 | $3K | 242,893 |
| 2010-03-15 | BROENNIMAN EDWARD G Director | Sale | −6,700 | $0.38 | $3K | 475,474 |
| 2010-03-15 | BARRY FRANKLYN S JR Director | Sale | −6,700 | $0.40 | $3K | 249,893 |
| 2009-12-30 | Joyce James A Chair., Pres., CEO, CFO, Sec. | Gift | −300,000 | 400,000 | ||
| 2009-11-25 | BROENNIMAN EDWARD G Director | Sale | −100,000 | $0.35 | $35K | 482,174 |
| 2008-12-15 | BARRY FRANKLYN S JR Director | Grant or award · Stock Options (right to buy) | +500,000 | 766,417 | ||
| 2008-12-15 | Tullis Richard VP, Chief Science Officer | Grant or award · Stock Options (right to buy) | +750,000 | 2,764,350 | ||
| 2008-12-15 | Joyce James A Chairman, Pres, CEO, CFO, Secy | Grant or award · Stock Options (right to buy) | +2,000,000 | 9,588,243 | ||
| 2008-12-15 | BROENNIMAN EDWARD G Director | Grant or award · Stock Options (right to buy) | +500,000 | 1,020,050 | ||
| 2008-07-31 | Tullis Richard VP, Chief Science Officer | Grant or award | +468,750 | $0.32 | $150K | 526,750 |
| 2008-07-28 | BROENNIMAN EDWARD G Director | Grant or award | +446,300 | $0.33 | $147K | 582,174 |
| 2008-07-24 | Joyce James A Chief Executive Secretary | Grant or award | +100,000 | $0.35 | $35K | 700,000 |
| 2008-03-19 | BARRY FRANKLYN S JR Director | Grant or award | +250,000 | $0.38 | $95K | 256,593 |
| 2008-03-19 | BARRY FRANKLYN S JR Director | Grant or award · Stock Option | +250,000 | $0.38 | $95K | 264,500 |
Page 17 of 18 · 360 trades